EN
HI
Clinitech Laboratory Chart
Clinitech Laboratory Share Key Metrics
Volume
0.00
Market Cap
9.41 CR
LTQ@LTP
0@41.25
ATP
0
Var Margin
100 %
Circuit Range
33-49.5
Delivery %
100 %
Value
0.00
ASM/GSM
No
Market Lot
1200
Summary
Clinitech Laboratory share price stands at ₹41.25 at 5 May, 2026 | 16:00. The stock Clinitech Laboratory intraday movement has stayed between ₹00 and ₹00, while on a 52-week basis it has fluctuated from ₹28.55 to ₹57.00.
In terms of trading activity, Clinitech Laboratory has recorded a volume of 0 shares. The Clinitech Laboratory has a market cap of ₹2282400. The stock’s Average Traded Price (ATP) stands at ₹0, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 0, 4125.
The Clinitech Laboratory operates within a circuit range of ₹33-49.5 – ₹33-49.5, with a Value of ₹0.00. The Delivery Percentage for the day is 100%. Additionally, Clinitech Laboratory currently falls under the No framework, and trades with a market lot size of 1200.
Clinitech Laboratory Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
55.26
Sector P/B
-15.97
Sec. Div. Yield
1.88
Clinitech Laboratory Resistance and Support
Pivot 41.25
Resistance
First Resistance
41.5
Second Resistance
41.75
Third Resistance
42
Support
First Support
41
Second Support
40.75
Third Support
40.5
Clinitech Laboratory Corporate Actions
| Date | Agenda |
|---|---|
| 2025-11-22 | Others |
| 2025-11-12 | Half Yearly Results |
| 2025-08-19 | Others |
| 2025-06-06 | Others |
| 2025-05-23 | Audited Results |
| 2025-03-25 | Others |
Clinitech Laboratory News
Clinitech Laboratory Ltd - 544220 - General Update Under Reg 30 Of SEBI (LODR) Regulations For Change In Market Maker
Clinitech Laboratory Limited's Board approved a change in market maker from SVCM Securities Private Limited to Kalpalabdhi Financials Private Limited. The change is effective from April 10, 2026, following SVCM's internal restructuring and involves a tripartite agreement with Inventure Merchant Banker Services.
Apr 09 2026 15:04:00
Clinitech Laboratory Ltd - 544220 - General Update W.R.T Receipt Of Letter From Promoter Under Reg 31(4) Of SEBI (SAST) Regulations For The Year Ended March 31, 2026
Clinitech Laboratory's promoter group declared no encumbrance on shares for the financial year ended March 31, 2026. Promoter Jagdish Umakant Nayak also acquired 9,600 additional shares on March 30, 2026, enhancing promoter holding.
Apr 06 2026 16:04:00
About Clinitech Laboratory
NSE : 0
BSE : 544220
ISIN : INE0QMR01015
Our Company was incorporated as Clinitech Laboratory Private Limited on March 19 2010 under the Companies Act 1956 with the Registrar of Companies Mumbai bearing Registration number 201078. The status of the Company was changed to public limited and the name of our Company was changed to Clinitech Laboratory Limited vide Special Resolution dated July 24 2023 pursuant to conversion of the Company into public limited Company. The fresh certificate of incorporation consequent to conversion was issued on August 25 2023 by the Registrar of Companies Mumbai.Our corporate identification number is U85195MH2010PLC201078.Major Events and Milestones:2010-Incorporation of our Company.2012-Established new Lab at Kalyan2016-NABL Accreditation at Airoli Centre2018-Established new Lab at Thane2021-NABL Accreditation for SARS-COV-2 testing-Signed up agreements for Diagnostic Centre at Kharghar2022-Signed up agreements for Diagnostic Centre at Panvel / Badlapur2023-Converted Company to Limited-Established new Lab at Murbad
Clinitech Laboratory Management
| Name | Position |
|---|---|
| Jagdish Umakant Nayak | Chairman & Managing Director |
| Jyoti Jagdish Nayak | Whole Time Director |
Clinitech Laboratory Similar Stocks
Cian Healthcare Ltd.
8.26
0.00 (0.00%)
Beryl Drugs Ltd.
21.75
-1.14 (4.98%)
Starsource Multitrade Ltd.
121.80
-1.20 (0.98%)
Sharma East India Hospitals & Medical Research Ltd
103.00
0.22 (0.21%)
Norris Medicines Ltd.
14.75
0.64 (4.54%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Parmax Pharma Ltd.
32.00
-0.50 (1.54%)
Colinz Laboratories Ltd.
50.00
1.70 (3.52%)
Broach Lifecare Hospital Ltd.
16.00
0.00 (0.00%)
Clinitech Laboratory FAQs
The Buying Price of Clinitech Laboratory share is 41.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Clinitech Laboratory stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Clinitech Laboratory, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Clinitech Laboratory shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Clinitech Laboratory shares is 0. Useful to assess the stock's value relative to its book value.
To assess Clinitech Laboratory’s valuation compare Sector P/E, P/B which are 55.26 & -15.97 with sector averages, along with growth rates and financial metrics.
The Market Cap of Clinitech Laboratory is 9.41 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Clinitech Laboratory share price is 57.00 & 28.55. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Clinitech Laboratory belongs to the Healthcare sector.
